Amazing Spider-Man #300: The Price Arc of a Modern Grail
First full Venom appearance. CGC 9.8 has gone from $400 in 2010 to $5,500+ today. Tracing the inflection points.
The Book: Amazing Spider-Man #300 (1988), McFarlane art, first full Venom appearance (Venom cameo in #299). The defining modern key — every Copper Age investing thesis runs through this issue.
CGC 9.8 Price Arc
| Year | CGC 9.8 | Catalyst |
|---|---|---|
| 1988 | $1.50 (cover) | Issue release |
| 2010 | $420 | Pre-Sony Venom era |
| 2017 | $1,200 | Sony Venom film announced |
| 2018 | $2,100 | Venom (2018) released, $856M box office |
| 2021 | $8,400 (peak) | Speculative bubble, Venom 2 anticipation |
| 2023 | $3,200 | Post-bubble correction |
| 2026 | $5,500 | Stabilized; CGC 9.8 pop now 1,844 |
Why It Sustained
- Venom is media-resilient. Three Sony films plus MCU integration plans. The character generates new audience cohorts every 3-5 years.
- McFarlane provenance. Even non-Venom fans want McFarlane. The art carries premium independent of character demand.
- Print run was massive but condition scarcity is real. 8 million issued, but only 1,844 CGC 9.8s. The black cover shows defects mercilessly.
- Pop scarcity at 9.9. Only 4 CGC 9.9s exist. Last public 9.9 sale was $87,500 in 2022.
Sub-Variants Worth Knowing
Forward View
ASM #300 is unlikely to revisit 2021 highs without a major catalyst. The current $5,500 level looks defensible — supported by McFarlane provenance, Venom's ongoing media presence, and CGC 9.8 supply that's growing slowly.
The asymmetric play: CGC 9.6s and 9.4s. Both grades have larger pops but trade at fractions of 9.8 prices ($1,400 and $700 respectively). If the 9.8 climbs to $7K, mid-grades typically lift proportionally — and they're less exposed to grade-pop bloat.